Shares shifted as Ubtech Robotics' German-listed stock (7US.MU) climbed 7.1% to $10.84, propelled by investor excitement over a partnership with aviation giant Airbus. Ubtech signed a cooperation agreement with Airbus, which includes the purchase of the company's industrial humanoid robot for use in Airbus manufacturing facilities. The deal is splashy, but the gap between a concept test and a revenue engine remains wide.
An Aerospace Giant Is Testing, Not Buying at Scale. Airbus said the cooperation is currently limited to early-stage concept testing, with no indication yet of wider industrial deployment.
Neither side has disclosed how many robots are involved or the deal's value , and the agreement focuses on trials rather than full-scale deployment. Investors are pricing in a future that Airbus itself has not committed to.
Big-Name Clients Are Lining Up — Revenue Is Following, Slowly. At home, Ubtech has already placed its robots with major customers including electric vehicle maker BYD and electronics giant Foxconn.
The deal follows a similar partnership with US semiconductor maker Texas Instruments, underscoring the firm's accelerated overseas push.
In 2025, Ubtech's humanoid robot orders totaled more than 1.4 billion yuan ($200 million), ranking first globally. Yet the company's 2025 revenue hit CN¥2 billion — up 53% from the prior year, though the net loss was still CN¥703 million (roughly $97 million). Marquee logos don't yet equal profitability.
Production Is Ramping, But Profits Remain Years Away. As of late December, around 1,000 Walker S2 units had been produced at Ubtech's factory in Liuzhou, southern China.
The company says production capacity for industrial humanoid robots is expected to surpass 10,000 units in 2026.
Analysts have raised their 2026 revenue forecast to CN¥3.69 billion, but still expect a loss of CN¥0.665 per share.
The company is not expected to turn a profit until 2027.
Valuation Runs on Faith in the Humanoid Future. Twelve analysts rate the Hong Kong-listed shares a "Strong Buy" with an average price target implying 75% upside. But with no positive earnings and a market cap around HK$54 billion (~$7 billion), the stock trades entirely on future expectations. The Airbus deal validates the concept; shareholders are betting it validates the business model — a distinction the market has yet to price correctly.